Danel (Adir Yeoshua) Ltd (TLV:DANE)
Israel
· Delayed Price · Currency is ILS · Price in ILA 37,300
-130 (-0.35%)
Apr 1, 2025, 4:47 PM IDT
Danel (Adir Yeoshua) Revenue
In the year 2024, Danel (Adir Yeoshua) had annual revenue of 2.77B ILS with 10.20% growth. Danel (Adir Yeoshua) had revenue of 710.60M in the quarter ending December 31, 2024, with 9.45% growth.
Revenue
2.77B
Revenue Growth
+10.20%
P/S Ratio
0.77
Revenue / Employee
699.35K
Employees
3,961
Market Cap
2.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.77B | 256.31M | 10.20% |
| Dec 31, 2023 | 2.51B | 149.89M | 6.34% |
| Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
| Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
| Dec 31, 2020 | 1.98B | 306.79M | 18.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 982.96M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |
| Golden House | 47.96M |